Exploring the Systemic Immune-Inflammation Index as a novel biomarker for nonalcoholic fatty liver disease: a systematic review and meta-analysis. [PDF]
Mirchandani M +10 more
europepmc +1 more source
ABSTRACT A substantial proportion of fresh fruit undergoes processing, resulting in underutilized fruit by‑products (FBPs) that are rich in dietary fiber and bioactive compounds. Recent FBP valorization trends demonstrate that fermentation significantly enhances microbiological, nutritional, and sensory attributes, yielding value‑added food supplements.
Abouzar Ghasemi +3 more
wiley +1 more source
Carvacrol-Loaded Chitosan Nanoparticles as a Multifunctional Nanotherapeutic Strategy Targeting Oxidative Stress, Inflammation, Apoptosis, and Genotoxicity in Nonalcoholic Fatty Liver Disease. [PDF]
Alfawaz M +7 more
europepmc +1 more source
ABSTRACT Lactic acid bacteria (LAB) are frequently used as health supplements. They enhance digestion, regulate immunity, improve gut microbiota, and prevent and manage diseases. Autophagy has a crucial role in the prevention and treatment of tumors, cardiovascular diseases, and pathogenic infections.
Yang Chen +8 more
wiley +1 more source
Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease. [PDF]
Yu H, Wan M, Li H, Liu X.
europepmc +1 more source
Recent Advances in the Bioactive Compounds of Prunes (Prunus domestica L.) and Their Health Benefits
Prunes (Prunus domestica L.) are a functional food rich in diverse bioactive compounds, including polyphenols (such as chlorogenic acid and anthocyanins), polysaccharides, and sorbitol.This review comprehensively synthesizes current research on the nutritional composition and biological activities of prunes, highlighting their multifaceted health ...
Luyang Han +10 more
wiley +1 more source
Metabolic traits as mediators between excess salt intake and the risk of nonalcoholic fatty liver disease. [PDF]
Li R, Hu K, Cui L, Sun S, Xie Y.
europepmc +1 more source
Our study did not find that aspirin significantly reduces the risk of liver fibrosis in patients with MASLD. Therefore, the long‐term use of aspirin solely for the prevention of liver fibrosis progression cannot be recommended in patients without high cardiovascular or cerebrovascular risk.
Linlin Yin, Bin Zhang
wiley +1 more source
Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization Study. [PDF]
Su Y +6 more
europepmc +1 more source
Ameliorative Effect of Beetroot Against Folic Acid Deficiency: A Review
Beets, as well as folic acid supplements, provide a possible nutritional intervention for nutritional insufficiency, and this is especially true in functional foods. Offering a holistic explanation of beetroot's medicinal properties, this paper explores the means by which its bioactive constituents can counteract the adverse effects of folic acid ...
Amara Rasheed +7 more
wiley +1 more source

